Previous tumour as a prognostic factor in stage I non-small cell lung cancer

Thorax

Volumn 62, Issue 5, 2007, Pages 386-390

  López Encuentra, Angel ^a   Gómez De La Cámara, Agustín ^a   Rami Porta, Ramón ^b   Duque Medina, José Luis ^c   Martín De Nicolás, José Luis ^a   Sayas, Javier ^a   Duque, José Luis ^c   Astudillo, Julio ^d   López De Castro, Pedro ^d   Canalís, Emillo ^e   Cantó Armengod, Antonio ^f   Arnau, Antonio ^f   Casanova, Juan ^g   Cerezal, Jorge ^c   Fernández De Rota, Antonio ^h   Arrabal, Ricardo ^h   González Aragoneses, Federico ⁱ   Moreno Mata, Nicolás ⁱ   Freixinet, Jorge ^j   Rodríguez Suárez, Pedro ^j   Llobregat Poyán, Nicolás ^k   Mañes, Nuria ^l   Hernández, Helena ^l   Serra Mitjans, Mireia ^b   Belda Sanchis, José ^b   Novoa Valentín, Nuria ^m   Rodríguez, Jesús ⁿ   Linera, Antonio ⁿ   Torres García, Antonio José ^o   Gómez, Ana ^o   De La Torre, Mercedes ^p   Sánchez Palencia Ramos, Abel ^q   Ruiz Zafra, Javier ^q   Varela Ugarte, Andrés ^r   Yat, Wah Pun ^s   Pozo Rodríguez, Francisco ^a   Ferrando, Paloma ^a   more..

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL MÚTUA DE TERRASSA   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

^f HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^g HOSPITAL DE CRUCES   (Spain)

^h HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

ⁱ HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^j HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^k HOSPITAL CENTRAL DE LA DEFENSA GÓMEZ ULLA   (Spain)

^l Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^m Universidad de Salamanca   (Spain)

ⁿ Servicio de Geriatría   (Spain)

^o HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^p HOSPITAL JUAN CANALEJO   (Spain)

^q HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^r HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^s HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; COMORBIDITY; CONTROLLED STUDY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; THORACOTOMY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CAUSE OF DEATH; COMORBIDITY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SPAIN;

EID: 34247896934     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2005.051615     Document Type: Article

References (35)

1. Read WL, Tierney RM, Page NC, et al. Differential prognostic impact of comorbidity. J Clin Oncol 2004;22:3099-103.
2. Lopez-Encuentra A, GCCB-S. Comorbidity in operable lung cancer: a multicenter descriptive study on 2992 patients. Lung Cancer 2002;35:263-9.
3. Piccirillo JF, Feinstein AR. Clinical symptoms and comorbidity: significance for the prognostic classification of cancer. Cancer 1996;77:834-42.
4. Battafarano RJ, Piccirillo JF, Meyers BF, et al. Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2002;123:280- 7.
5. Lopez-Encuentra A, Astudillo J, Cerezal J, et al. Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery (GCCB-S). Prognostic value of chronic obstructive pulmonary disease in 2994 cases of lung cancer. Eur J Cardiothorac Surg 2005;27:8-13.
6. Johnson BE. Second lung cancers in patients after treatment for an initial lung cancer. J Natl Cancer Inst 1998;90:1335-45.
7. Koppe MJ, Zoetmulder FA, van Zandwijk N, et al. The prognostic significance of a previous malignancy in operable non-small cell lung cancer. Lung Cancer 2001;32:47-53.
8. Liu YY, Chen YM, Yen SH, et al. Multiple primary malignancies involving lung cancer-clinical characteristics and prognosis. Lung Cancer 2002;35:189-94.
9. Duchateau CS, Stokkel MP. Second primary tumors involving non-small cell lung cancer: prevalence and its influence on survival. Chest 2005;127:1152-8.
10. Braakhuis BJ, Tabor MP, Kummer JA, et al. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 2003;63:1727-30.
11. Sobin LH, Wittekind Ch. UICC International Union Against Cancer: TNM classification of malignant tumours, 5th ed. New York: Wiley-Liss, 1997:91-7.
12. López Encuentra A, the Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology, Thoracic Surgery (GCCB-S). Criteria of functional and oncological operability in surgery for lung cancer. A multicenter study. Lung Cancer 1998;20:161-8.
13. López Encuentra A, Gómez de la Cámara A, Varela de Ugarte A, et al. El "fenómeno Will-Rogers". Migración de estadios en carcinoma broncogénico, tras aplicar criterios de certeza clasificatoria. Arch Bronconeumol 2002;38:166-71.
14. American Thoracic Society. Clinical staging primary lung cancer. Am Rev Respir Dis 1983;127:659-64.
15. Izbicki JR, Passlick B, Karg O, et al. Impact of radical systematic mediastinal lymphadenectomy on tumor staging in lung cancer. Ann Thorac Surg 1995;59:209-14.
16. López Encuentra A, Gómez de la Cámara A, for the Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology, Thoracic Surgery (GCCB-S). Validation of a central review board of staging prior to surgery for non-small-cell lung cancer - impact on prognosis: a multicenter study. Respiration 2002;69:16-24.
17. Lopez-Encuentra A, Duque-Medina JL, Rami-Porta R, et al. Staging in lung cancer: is 3 cm a prognostic threshold in pathologic stage I non-small cell lung cancer? A multicenter study of 1,020 patients. Chest 2002;121:1515-20.
18. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley, 1989.
19. Brundage MD, Davies D, Mackillop WJ. Prognostic factors in non-small cell lung cancer: a decade of progress. Chest 2002;122:1037-57.
20. Padilla J, Carvo V, Peñalver JC, et al. Surgical results and prognostic factors in early non-small cell lung cancer. Ann Thorac Surg 1997;63:324-6.
21. Manac'h D, Riquet M, Medioni J, et al. Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor. Ann Thorac Surg 2001;71:1088-93.
22. Shimizu K, Yoshida J, Nagai K, et al. Visceral pleural invasion classification in non-small cell lung cancer: a proposal on the basis of outcome assessment. J Thorac Cardiovasc Surg 2004;127:1574-8.
23. Osoki T, Nagashima A, Yoshimatsu T, et al. Visceral pleural involvement in nonsmall celllung cancer: prognostic significance. Ann Thorac Surg 2004;77:1769-73.
24. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;111:1710-7.
25. Pastorino U, Valente M, Bedini V, et al. Effect of chronic cardiopulmonary disease on survival after resection for stage la lung cancer. Thorax 1982;37:680-3.
26. Birim O, Maat AP, Kappetein AP, et al. Validation of the Charlson comorbidity index in patients with operated primary non-small cell lung cancer. Eur J Cardiothorac Surg 2003;23:30-4.
27. Lopez-Encuentra A, Pozo-Rodriguez F, Martin-Escribano P, et al. Surgical lung cancer. Risk operative analysis. Lung Cancer 2004;44:327-37.
28. Solan MJ, Werner-Wasik M. Prognostic factors in non-small cell lung cancer. Semin Surg Oncol 2003;21:64-73.
29. Firat S, Bousamra M, Gore E, et al. Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2002;52:1047-57.
30. Kaplan MH, Feinstein AR. The importance of classifying initial co-morbidity in evaluatin the outcome of diabetes mellitus. J Chronic Dis 1974;27:387-404.
31. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
32. Tammemagi CM, Neslund-Dudas C, Simoff M, et al. Impact of comorbidity on lung cancer survival. Int J Cancer 2003;103:792- 802.
33. Janssen-Heijnen ML, Smulders S, Lemmens VE, et al. Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer. Thorax 2004;59:602-7.
34. Brock MV, Alberg Al, Hooker CM, et al. Risk of subsequent primary neoplasms developing in lung cancer patients with prior malignancies. J Thorac Cardiovasc Surg 2004;127:1119-25.
35. Askling J, Sorensen P, Ekbom A, et al. Is history of squamous-cell skin cancer a marker of poor prognosis in patients with cancer? Ann Intern Med 1999;131:655-9.